Clinical Trial Update: Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase II trial evaluating fixed-dose-rate gemcitabine in patients with advanced or metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED